DEVON, Pa., Nov. 09, 2016 — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will participate at various upcoming investor meetings and conferences.
Armando Anido, Chairman and CEO, will present at the Jefferies London Healthcare Conference in London, UK, on November 17, 2016 at 2:00 pm GMT.
Jim Fickenscher, CFO and VP Corporate Development, will present at the Stifel 2016 Healthcare Conference in New York City on November 16, 2016 at 1:30 pm ET. Mr. Fickenscher will be joined by Donna Gutterman, PharmD, VP Medical, in participation at the Maxim Group Central Nervous Disease Conference in New York City on November 17, 2016.
To listen to a webcast of the Jefferies or Stifel presentations live, please visit the Investor Relations page of www.zynerba.com. A replay of both webcasts will be